American College of Clinical Pharmacy
13
1
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
7.7%
1 terminated/withdrawn out of 13 trials
91.7%
+5.2% vs industry average
38%
5 trials in Phase 3/4
55%
6 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Pharmacogenomics of Heparin-Induced Thrombocytopenia
Role: collaborator
Role of Exogenous and Endogenous Sex Hormones on Tenofovir and Emtricitabine Disposition in Female Genital Tract
Role: collaborator
A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury
Role: collaborator
A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome
Role: collaborator
Shared Medical Appointments for Weight Loss
Role: collaborator
Pharmacogenetics to Predict Drug Interactions in Kidney Transplant Recipients
Role: collaborator
Histamine Pharmacogenetics in Children With Atopic Dermatitis
Role: collaborator
Digoxin Dosing in Heart Failure: A Simplified Nomogram Versus Standard Care
Role: collaborator
Assessment of Biomarkers and Cardiorenal Syndrome in Acute Decompensated Heart Failure With Vasodilator Therapy
Role: collaborator
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
Role: collaborator
LXRA Gene Polymorphisms and Response to Fenofibrate
Role: collaborator
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
Role: collaborator
Exercise Induced Bronchospasm in Children
Role: collaborator
All 13 trials loaded